메뉴 건너뛰기




Volumn 27, Issue 3, 2014, Pages 482-489

Intestinal microbiota and probiotics in celiac disease

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

EID: 84903633185     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00106-13     Document Type: Article
Times cited : (88)

References (50)
  • 2
    • 70649092298 scopus 로고    scopus 로고
    • Celiac disease: From pathogenesis to novel therapies
    • Schuppan D, Junker Y, Barisani D. 2009. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 137:1912-1933. http://dx.doi.org/10.1053/j.gastro.2009.09.008.
    • (2009) Gastroenterology , vol.137 , pp. 1912-1933
    • Schuppan, D.1    Junker, Y.2    Barisani, D.3
  • 3
    • 77957804137 scopus 로고    scopus 로고
    • Coeliac disease: Clinical features in adult populations
    • Fernández A, González L, De La Fuente J. 2010. Coeliac disease: clinical features in adult populations. Rev. Esp. Enferm. Dig. 102:466-471. http: //www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt_4 619000&TO_RVN&Eng_1.
    • (2010) Rev. Esp. Enferm. Dig. , vol.102 , pp. 466-471
    • Fernández, A.1    González, L.2    De La Fuente, J.3
  • 5
    • 33748885488 scopus 로고    scopus 로고
    • Chemistry of gluten proteins
    • Wieser H. 2007. Chemistry of gluten proteins. Food Microbiol. 24:115-119. http://dx.doi.org/10.1016/j.fm.2006.07.004.
    • (2007) Food Microbiol. , vol.24 , pp. 115-119
    • Wieser, H.1
  • 6
    • 0025165404 scopus 로고
    • Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles
    • Spurkland A, Sollid LM, Ronningen KS, Bosnes V, Ek J, Vartdal F, Thorsby E. 1990. Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. Hum. Immunol. 29:157-165. http://dx.doi.org/10.1016/0198-8859(90)90111-2.
    • (1990) Hum. Immunol. , vol.29 , pp. 157-165
    • Spurkland, A.1    Sollid, L.M.2    Ronningen, K.S.3    Bosnes, V.4    Ek, J.5    Vartdal, F.6    Thorsby, E.7
  • 8
    • 84867670979 scopus 로고    scopus 로고
    • Pathophysiology of celiac disease
    • Kupfer SS, Jabri B. 2012. Pathophysiology of celiac disease. Gastrointest. Endosc. Clin. N. Am. 22:639-660. http://dx.doi.org/10.1016/j.giec.2012.07.003.
    • (2012) Gastrointest. Endosc. Clin. N. Am. , vol.22 , pp. 639-660
    • Kupfer, S.S.1    Jabri, B.2
  • 9
    • 79960771951 scopus 로고    scopus 로고
    • New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment
    • Lionetti E, Catassi C. 2011. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int. Rev. Immunol. 30:219-231. http://dx.doi.org/10.3109/08830185.2011.602443.
    • (2011) Int. Rev. Immunol. , vol.30 , pp. 219-231
    • Lionetti, E.1    Catassi, C.2
  • 13
    • 33947188192 scopus 로고    scopus 로고
    • Differences between the fecal microbiota of coeliac infants and healthy controls
    • Collado M, Calabuig M, Sanz Y. 2007. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr. Issues Intest. Microbiol. 8:9-14.
    • (2007) Curr. Issues Intest. Microbiol. , vol.8 , pp. 9-14
    • Collado, M.1    Calabuig, M.2    Sanz, Y.3
  • 14
    • 0027409890 scopus 로고
    • Intestinal permeability in patients with coeliac disease and relatives of patients with celiac disease
    • Van Elburg RM, Uil JJ, Mulder CJ, Heymans HSA. 1993. Intestinal permeability in patients with coeliac disease and relatives of patients with celiac disease. Gut 34:354-357. http://dx.doi.org/10.1136/gut.34.3.354.
    • (1993) Gut , vol.34 , pp. 354-357
    • Van Elburg, R.M.1    Uil, J.J.2    Mulder, C.J.3    Heymans, H.S.A.4
  • 15
    • 78751699186 scopus 로고    scopus 로고
    • Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer
    • Fasano A. 2011. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91:151-175. http://dx.doi.org/10.1152/physrev.00003.2008.
    • (2011) Physiol. Rev. , vol.91 , pp. 151-175
    • Fasano, A.1
  • 17
    • 84855387746 scopus 로고    scopus 로고
    • Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury
    • Frazier TH, DiBaise JK, McClain CJ. 2011. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J. Parenter. Enteral Nutr. 35:14S-20S. http://dx.doi.org/10.1177/0148607111413772.
    • (2011) J. Parenter. Enteral Nutr. , vol.35
    • Frazier, T.H.1    DiBaise, J.K.2    McClain, C.J.3
  • 19
    • 79959201412 scopus 로고    scopus 로고
    • Human nutrition, the gut microbiome and the immune system
    • Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. 2011. Human nutrition, the gut microbiome and the immune system. Nature 474:327-336. http://dx.doi.org/10.1038/nature10213.
    • (2011) Nature , vol.474 , pp. 327-336
    • Kau, A.L.1    Ahern, P.P.2    Griffin, N.W.3    Goodman, A.L.4    Gordon, J.I.5
  • 22
  • 24
    • 84876377297 scopus 로고    scopus 로고
    • The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease
    • Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, Mäki M, Mättö J. 2013. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm. Bowel Dis. 19:934-941. http://dx.doi.org/10.1097/MIB.0b013e31828029a9.
    • (2013) Inflamm. Bowel Dis. , vol.19 , pp. 934-941
    • Wacklin, P.1    Kaukinen, K.2    Tuovinen, E.3    Collin, P.4    Lindfors, K.5    Partanen, J.6    Mäki, M.7    Mättö, J.8
  • 25
    • 35948957475 scopus 로고    scopus 로고
    • Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis
    • Sanz Y, Sánchez E, Marzotto M, Calabuig M, Torriani S, Dellaglio F. 2007. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol. Med. Microbiol. 51:562-568. http://dx.doi.org/10.1111 /j.1574-695X.2007.00337.x.
    • (2007) FEMS Immunol. Med. Microbiol. , vol.51 , pp. 562-568
    • Sanz, Y.1    Sánchez, E.2    Marzotto, M.3    Calabuig, M.4    Torriani, S.5    Dellaglio, F.6
  • 26
    • 37249066238 scopus 로고    scopus 로고
    • Imbalance in the composition of the duodenal microbiota of children with coeliac disease
    • Nadal I, Donant E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2007. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56:1669-1674. http://dx.doi.org/10.1099/jmm.0.47410-0.
    • (2007) J. Med. Microbiol. , vol.56 , pp. 1669-1674
    • Nadal, I.1    Donant, E.2    Ribes-Koninckx, C.3    Calabuig, M.4    Sanz, Y.5
  • 27
    • 60549097418 scopus 로고    scopus 로고
    • Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease
    • Collado M, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2008. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMCMicrobiol. 8:232. http://dx.doi.org/10.1186/1471-2180-8-232.
    • (2008) BMC Microbiol. , vol.8 , pp. 232
    • Collado, M.1    Donat, E.2    Ribes-Koninckx, C.3    Calabuig, M.4    Sanz, Y.5
  • 28
    • 61849116850 scopus 로고    scopus 로고
    • Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease
    • Collado M, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2009. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 62:264-269. http://dx.doi.org/10.1136/jcp.2008.061366.
    • (2009) J. Clin. Pathol. , vol.62 , pp. 264-269
    • Collado, M.1    Donat, E.2    Ribes-Koninckx, C.3    Calabuig, M.4    Sanz, Y.5
  • 30
    • 77952539331 scopus 로고    scopus 로고
    • Pivotal advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease
    • De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. 2010. Pivotal advance: bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J. Leukoc. Biol. 87:765-778. http://dx.doi.org/10.1189/jlb.0709471.
    • (2010) J. Leukoc. Biol. , vol.87 , pp. 765-778
    • De Palma, G.1    Cinova, J.2    Stepankova, R.3    Tuckova, L.4    Sanz, Y.5
  • 32
    • 24944540682 scopus 로고    scopus 로고
    • Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes
    • Wang M, Ahrne S, Jeppsson B, Molin G. 2005. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol. Ecol. 54:219-231. http://dx.doi.org/10.1016/j.femsec.2005.03.012.
    • (2005) FEMS Microbiol. Ecol. , vol.54 , pp. 219-231
    • Wang, M.1    Ahrne, S.2    Jeppsson, B.3    Molin, G.4
  • 33
    • 3242809884 scopus 로고    scopus 로고
    • Microbiota composition of the intestinal mucosa: Association with fecal microbiota?
    • Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E. 2004. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol. Immunol. 48:497-500. http://dx.doi.org/10.1111 /j.1348-0421.2004.tb03544.x.
    • (2004) Microbiol. Immunol. , vol.48 , pp. 497-500
    • Ouwehand, A.C.1    Salminen, S.2    Arvola, T.3    Ruuska, T.4    Isolauri, E.5
  • 34
    • 0037295590 scopus 로고    scopus 로고
    • Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients
    • Setoyama H, Imaoka A, Ishikawa H, Umesaki Y. 2003. Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. Microbes Infect. 5:115-122. http://dx.doi.org/10.1016/S1286-4579(02)00080-1.
    • (2003) Microbes Infect. , vol.5 , pp. 115-122
    • Setoyama, H.1    Imaoka, A.2    Ishikawa, H.3    Umesaki, Y.4
  • 36
    • 84856722514 scopus 로고    scopus 로고
    • The impact of perinatal probiotic intervention on gut microbiota: Double-blind placebo-controlled trials in Finland and Germany
    • Grzeskowiak LM, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. 2012. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 18:7-13. http://dx.doi.org/10.1016/j.anaerobe.2011.09.006.
    • (2012) Anaerobe , vol.18 , pp. 7-13
    • Grzeskowiak, L.M.1    Grönlund, M.M.2    Beckmann, C.3    Salminen, S.4    von Berg, A.5    Isolauri, E.6
  • 41
    • 0035109676 scopus 로고    scopus 로고
    • Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum
    • Fasano A, Catassi C. 2001. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636-651. http://dx.doi.org/10.1053/gast.2001.22123.
    • (2001) Gastroenterology , vol.120 , pp. 636-651
    • Fasano, A.1    Catassi, C.2
  • 42
    • 17144453845 scopus 로고    scopus 로고
    • Better dietary compliance in patients with coeliac diseasediagnosedin early childhood
    • Högberg L, Grodzinsky E, Stenhammar L. 2003. Better dietary compliance in patients with coeliac diseasediagnosedin early childhood. Scand. J. Gastroenterol. 38:751-754. http://dx.doi.org/10.1080/00365520310003318.
    • (2003) Scand. J. Gastroenterol. , vol.38 , pp. 751-754
    • Högberg, L.1    Grodzinsky, E.2    Stenhammar, L.3
  • 43
    • 84868005247 scopus 로고    scopus 로고
    • Emerging therapeutic options for celiac disease: Potential alternatives to a gluten-free diet
    • Bakshi A, Stephen S, Borum ML, Doman DB. 2012. Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet. Gastroenterol. Hepatol. 8:582-588. http://www.ncbi.nlm.nih.gov/pmc /articles/PMC3594957/.
    • (2012) Gastroenterol. Hepatol. , vol.8 , pp. 582-588
    • Bakshi, A.1    Stephen, S.2    Borum, M.L.3    Doman, D.B.4
  • 44
    • 84885896917 scopus 로고    scopus 로고
    • ftp://ftp.fao.org/es/esn/food/wgreport2.pdf, Food and Agriculture Organization of the United Nations, World Health Organization. World Health Organization, Geneva, Switzerland. Accessed 27 April 2014
    • Food and Agriculture Organization of the United Nations, World Health Organization. 2002. Guidelines for the evaluation of probiotics in food. World Health Organization, Geneva, Switzerland. ftp://ftp.fao.org /es/esn/food/wgreport2.pdf. Accessed 27 April 2014.
    • (2002) Guidelines for the evaluation of probiotics in food.
  • 45
    • 59249100550 scopus 로고    scopus 로고
    • Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases
    • Vanderpool C, Yan F, Polk DB. 2008. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm. Bowel Dis. 14:1585-1596. http://dx.doi.org/10.1002/ibd.20525.
    • (2008) Inflamm. Bowel Dis. , vol.14 , pp. 1585-1596
    • Vanderpool, C.1    Yan, F.2    Polk, D.B.3
  • 47
    • 43349099918 scopus 로고    scopus 로고
    • Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture
    • Lindfors K, Blomqvist T, Juuti-Uusitalo K, Stenman S, Venäläinen J, Mäki M, Kaukinen K. 2008. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin. Exp. Immunol. 152:552-558. http://dx.doi.org/10.1111/j.1365-2249.2008.03635.x.
    • (2008) Clin. Exp. Immunol. , vol.152 , pp. 552-558
    • Lindfors, K.1    Blomqvist, T.2    Juuti-Uusitalo, K.3    Stenman, S.4    Venäläinen, J.5    Mäki, M.6    Kaukinen, K.7
  • 48
    • 84856777535 scopus 로고    scopus 로고
    • Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model
    • Laparra JM, Olivares M, Gallina O, Sanz Y. 2012. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 7:e30744. http://dx.doi.org/10.1371 /journal.pone.0030744.
    • (2012) PLoS One , vol.7
    • Laparra, J.M.1    Olivares, M.2    Gallina, O.3    Sanz, Y.4
  • 49
    • 80052659382 scopus 로고    scopus 로고
    • Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy
    • D'Arienzo R, Stefanile R, Maurano F, Mazzarella G, Ricca E, Troncone R, Auricchio S, Rossi M. 2011. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand. J. Immunol. 74:335-341. http://dx.doi.org/10.1111/j.1365-3083.2011.02582.x.
    • (2011) Scand. J. Immunol. , vol.74 , pp. 335-341
    • D'Arienzo, R.1    Stefanile, R.2    Maurano, F.3    Mazzarella, G.4    Ricca, E.5    Troncone, R.6    Auricchio, S.7    Rossi, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.